Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-08-02

Clinical Trial Update: The Randomized Double-blind Placebo-controlled Trial of Intralesional Botulinum Toxin A Injection for Recalcitrant Alopecia Totalis and Alopecia Universalis [Phase 2, Phase 3]

View source ↗

Summary

A randomized double-blind, placebo-controlled trial tested intralesional botulinum toxin A for recalcitrant alopecia totalis and alopecia universalis; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Siriraj Hospital | Conditions: Recalcitrant Alopecia Totalis, Recalcitrant Alopecia Universalis | Phase 2, Phase 3 | Status: COMPLETED